Code Execution Vulnerability in Philips IntelliSpace Cardiovascular Products
CVE-2018-14787

7.8HIGH

Key Information:

Vendor

Philips
Status
Intellispace Cardiovascular (iscv) Products
Vendor
CVE Published:
22 August 2018

What is CVE-2018-14787?

In Philips' IntelliSpace Cardiovascular and Xcelera products, an escalation of privileges allows attackers to access writeable executable folders. Consequently, unauthorized users can execute arbitrary code under local administrative permissions, posing a significant security risk to sensitive medical data and operational systems.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

IntelliSpace Cardiovascular (ISCV) products IntelliSpace Cardiovascular, Version 3.1 or prior

IntelliSpace Cardiovascular (ISCV) products Xcelera Version 4.1 or prior

References

https://www.usa.philips.com/healthcare/about/customer-sup...
x_refsource_CONFIRM
https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01
x_refsource_MISC

CVSS V3.1

Score:
7.8
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.